Recall of Heart and Blood Pressure Med Affects 112,000 Bottles
The Food Drug Administration (FDA) announced a voluntary recall involving approximately 112,000 bottles of medications used to heart and. recall initiated due to concerns over contamination or labeling inaccuracies that could compromise patient safety.
Pharmaceutical companies identified issue during routine control procedures, prompting immediate action to prevent any adverse health effects. Patients currently using these medications are advised to consult their healthcare providers alternative treatment options and to avoid using the affected products until further notice.
Healthcare professionals are urged to review their inventories and ensure that affected bottles promptly from. FDA continues to monitor the closely and will provide updates as more information becomes. Consumers are to report any adverse reactions or concerns related to medications through official channels.
Discover more from -
Subscribe to get the latest posts sent to your email.
